131 related articles for article (PubMed ID: 9331896)
1. Expression of integrin subunits and CD44 isoforms in psoriatic skin and effects of topical calcitriol application.
Reichrath J; Horf R; Chen TC; Müller SM; Sanan D; Holick MF
J Cutan Pathol; 1997 Sep; 24(8):499-506. PubMed ID: 9331896
[TBL] [Abstract][Full Text] [Related]
2. Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation.
Reichrath J; Perez A; Müller SM; Chen TC; Kerber A; Bahmer FA; Holick MF
Acta Derm Venereol; 1997 Jul; 77(4):268-72. PubMed ID: 9228216
[TBL] [Abstract][Full Text] [Related]
3. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
[TBL] [Abstract][Full Text] [Related]
4. Effects of topical calcipotriol on the expression of adhesion molecules in psoriasis.
Savoia P; Novelli M; De Matteis A; Verrone A; Bernengo MG
J Cutan Pathol; 1998 Feb; 25(2):89-94. PubMed ID: 9521497
[TBL] [Abstract][Full Text] [Related]
5. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.
van Duijnhoven MW; Körver JE; Vissers WH; van Vlijmen-Willems IM; Pasch MC; van Erp PE; Van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):27-33. PubMed ID: 16405604
[TBL] [Abstract][Full Text] [Related]
7. Altered vascular endothelium integrin expression in psoriasis.
Creamer D; Allen M; Sousa A; Poston R; Barker J
Am J Pathol; 1995 Dec; 147(6):1661-7. PubMed ID: 7495291
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Exp Med; 1993 Oct; 178(4):1271-81. PubMed ID: 7690831
[TBL] [Abstract][Full Text] [Related]
9. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L
Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan and CD44 in psoriatic skin. Intense staining for hyaluronan on dermal capillary loops and reduced expression of CD44 and hyaluronan in keratinocyte-leukocyte interfaces.
Tammi R; Paukkonen K; Wang C; Horsmanheimo M; Tammi M
Arch Dermatol Res; 1994; 286(1):21-9. PubMed ID: 7511363
[TBL] [Abstract][Full Text] [Related]
11. Calcipotriol inhibits the proliferation of hyperproliferative CD29 positive keratinocytes in psoriatic epidermis in the absence of an effect on the function and number of antigen-presenting cells.
Jensen AM; Lladó MB; Skov L; Hansen ER; Larsen JK; Baadsgaard O
Br J Dermatol; 1998 Dec; 139(6):984-91. PubMed ID: 9990360
[TBL] [Abstract][Full Text] [Related]
12. CDw49b/CD29 integrin complex mediates the differentiation of human endothelial cells into capillary-like structures in vitro.
Kubota Y; Kawa Y; Mizoguchi M
J Dermatol Sci; 1996 Apr; 12(1):36-43. PubMed ID: 8740459
[TBL] [Abstract][Full Text] [Related]
13. Influence of cytokine stimulation (granulocyte macrophage-colony stimulating factor, interleukin-3 and transforming growth factor-beta-1) on adhesion molecule expression in normal human bone marrow fibroblasts.
Schmitz B; Park IA; Kaufmann R; Thiele J; Fischer R
Acta Haematol; 1995; 94(4):173-81. PubMed ID: 8610474
[TBL] [Abstract][Full Text] [Related]
14. Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment.
Nissen JB; Avrach WW; Hansen ES; Stengaard-Pedersen K; Kragballe K
Dermatology; 1999; 198(1):11-7. PubMed ID: 10026395
[TBL] [Abstract][Full Text] [Related]
15. Importance of the tubulointerstitium in human glomerulonephritis. II. Distribution of integrin chains beta 1, alpha 1 to 6 and alpha V.
Roy-Chaudhury P; Hillis G; McDonald S; Simpson JG; Power DA
Kidney Int; 1997 Jul; 52(1):103-10. PubMed ID: 9211352
[TBL] [Abstract][Full Text] [Related]
16. Distribution of integrins during human fetal lung development.
Coraux C; Delplanque A; Hinnrasky J; Peault B; Puchelle E; Gaillard D
J Histochem Cytochem; 1998 Jul; 46(7):803-10. PubMed ID: 9632739
[TBL] [Abstract][Full Text] [Related]
17. RNA, DNA, and cell surface characteristics of lesional and nonlesional psoriatic skin.
Staiano-Coico L; Gottlieb AB; Barazani L; Carter DM
J Invest Dermatol; 1987 May; 88(5):646-51. PubMed ID: 2437219
[TBL] [Abstract][Full Text] [Related]
18. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N
Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553
[No Abstract] [Full Text] [Related]
19. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC
Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
[TBL] [Abstract][Full Text] [Related]
20. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
